Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B

Gut

Volumn 46, Issue 3, 2000, Pages 420-426

  Fattovich, G ^a   Giustina, G ^b   Christensen, E ^c   Pantalena, M ^a   Zagni, I ^a   Realdi, G ^d   Schalm, S W ^e  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c BISPEBJERG HOSPITAL   (Denmark)

^d UNIVERSITY OF SASSARI   (Italy)

^e ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Decompensation; Delta hepatitis; Hepatocellular carcinoma; Prognosis; Survival

Indexed keywords

ALBUMIN; HEPATITIS B(E) ANTIGEN; IMMUNOGLOBULIN;

ADOLESCENT; ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER RISK; DELTA AGENT HEPATITIS; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; SURVIVAL;

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; CARCINOMA, HEPATOCELLULAR; CHILD; EUROPE; FEMALE; HEPATITIS D; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 0000452973     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.46.3.420     Document Type: Article

References (23)

1. 1 Rizzetto M. The Delta agent. Hepatology 1983;3:729-37.
2. 2 Caredda F, Rossi E, d'Arminio Monforte A, et al. Hepatitis B virus-associated coinfection and superinfection with δ agent: Indistinguishable disease with different outcome. J Infect Dis 1985;151:925-8.
3. 3 Rizzetto M, Verme G, Recchia S, et al. Chronic hepatitis in carriers of hepatitis B surface antigen, with intrahepatic expression of the Delta antigen. An active and progressive disease unresponsive to immunosuppressive treatment. Ann Intern Med 1983;98:437-41.
4. 4 Colombo M, Cambieri R, Rumi MG, et al. Long-term Delta superinfection in hepatitis B surface antigen carriers and its relationship to the course of chronic hepatitis. Gastroenterology 1983;85:235-9.
5. 5 Govindarajan S, Kanel GC, Peters RL. Prevalence of delta-antibody among chronic hepatitis B virus infected patients in the Los Angeles areas: Its correlation with liver biopsy diagnosis. Gastroenterology 1983;85:160-2.
6. 6 Sagnelli E, Felaco FM, Filippini P, et al. Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis. Liver 1989;9:229-34.
7. 7 Fattovich G, Boscaro S, Noventa F, et al. Influence of hepatitis delta virus infection on progression to cirrhosis in chronic hepatitis type B. J Infect Dis 1987;155:931-5.
8. 8 Realdi G, Fattovich G, Hadziyannis S, et al. Survival and prognostic factors in 366 patients with compensated cirrhosis type B: A multicenter study. J Hepatol 1994;21: 656-66.
9. 9 Bianchi L, De Groote J, Desmet VJ, et al. Acute and chronic hepatitis revisited. Lancet 1977;2:914-19.
10. 10 Kaplan EL, Meier P. Nonparametric estimation from incomplete observation. Journal of the American Statistical Association 1958;53:457-81.
11. 11 Peto R, Pike MC. Conservatism of the approximation (O-E)/E in the logrank test for survival data on tumor incidence data. Biometrics 1973;29:579-84.
12. 12 Cox DR. Regression models and life tables (with discussion). Journal of the Royal Statistics Society B 1972;34:187-220.
13. 13 Christensen E. Multivariate survival analysis using Cox's regression model. Hepatology 1987;7:1346-58.
14. 14 Beale EML, Little RJA. Missing values in multivariate analysis. Journal of the Royal Statistics Society B 1975;37: 129-45.
15. 15 Rizzetto M, Hadziyannis S, Hansson BG, et al. Hepatitis delta virus infection in the world: Epidemiological patterns and clinical expression. Gastroenterology International 1992; 5:19-32.
16. 16 Sagnelli E, Stroffolini T, Ascione A, et al. The epidemiology of hepatitis delta infection in Italy. J Hepatol 1992;15:211-15.
17. 17 Wu JC, Lee SD, Govindarajan S, et al. Correlation of serum delta RNA with clinical course of acute hepatitis delta virus superinfection in Taiwan: A longitudinal study. J Infect Dis 1990;161:1116-20.
18. 18 Hadziyannis SJ, Sherman M, Lieberman HM, et al. Liver disease activity and hepatitis B virus replication in chronic delta antigen-positive hepatitis B virus carriers. Hepatology 1985;5:544-7.
19. 19 Bonino F, Negro F, Baldi M, et al. The natural history of chronic delta hepatitis. In: Rizzetto M, Gerin JL, Purcell RH, eds. The Hepatitis Delta Virus and its Infection. New York: Alan Liss, 1987:145-52.
20. 20 De Man RA, Sprey RP, Niesters HGM, et al. Survival and complications in a cohort of patients with anti-Delta positive liver disease presenting in a tertiary referral clinic. J Hepatol 1995;23:662-7.
21. 21 Triger DR, Wright R. Hyperglobulinemia in liver disease. Lancet 1973;1;1494-6.
22. 22 Goresky CA, Huet PM, Villeneuve JP. Blood-tissue exchange and blood flow in the liver. In: Zakim D, Boyer TD, eds. Hepatology: A Textbook of Liver Disease. Philadelphia: WB Saunders Co, 1982:32-63.
23. 23 Genesca J, Gonzàles A, Torregrosa M, et al. High levels of endotoxin antibodies contribute to hyperglobulinemia of cirrhotic patients. Am J Gastroenterol 1998;4:664-5.